TrialBritish journal of clinical pharmacology2022

A Phase 1 study of the long-acting anti-IL-5 monoclonal antibody GSK3511294 in patients with asthma.

Dave Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.